Atlas Trials

Postoperative Adjuvant Chemotherapy With Bevacizumab and Maintenance Bevacizumab After Neoadjuvant Chemotherapy for Ovarian Cancer

Clinical trial NCT02022917 · COMPLETED

Trial details

NCT number
NCT02022917
Sponsor
Chang Gung Memorial Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Epithelial Ovarian Cancer
Start date
2014-03-01
Primary completion
2021-01-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.